What is the recommended treatment for a patient with retrolisthesis, considering their overall health and potential history of osteoporosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Retrolisthesis

Conservative management with physical therapy, activity modification, and pain control is the first-line treatment for retrolisthesis, with surgical decompression and fusion reserved for patients with progressive neurological deficits, severe pain refractory to conservative care, or documented spinal instability. 1

Initial Conservative Management

All patients with retrolisthesis should undergo at least 6 weeks of comprehensive conservative treatment before considering surgical intervention. 2 This approach is supported by high-quality evidence demonstrating that most patients with low-grade retrolisthesis (Grade I-II) experience symptom relief without surgery. 1

Conservative Treatment Components

  • Physical therapy with core strengthening exercises, stretching, and supervised rehabilitation is the cornerstone of conservative management. 2, 3
  • NSAIDs should be used for pain management as first-line pharmacologic therapy. 2, 1
  • Epidural steroid injections are recommended for patients with radiculopathy, producing equivalent improvements regardless of stenosis severity. 2
  • Activity modification and patient education are essential components of the conservative approach. 2
  • Patients should remain active rather than undergo bed rest, as activity is more effective for symptom management. 2
  • Chiropractic manipulation, axial distraction, and isometric stretching may provide benefit in selected cases, with evidence showing gradual reduction in retrolisthesis severity over long-term maintenance care. 3

When to Consider Osteoporosis Management

If the patient has a history of osteoporosis or is at risk (postmenopausal women, patients on chronic glucocorticoids), concurrent treatment is essential:

  • For adults ≥40 years at moderate-to-high fracture risk, oral bisphosphonates are the first-line treatment (strong recommendation for high risk; conditional for moderate risk). 4
  • Calcium 1,000-1,200 mg/day and vitamin D 600-800 IU/day (serum level ≥20 ng/ml) should be provided to all patients. 4
  • Alternative agents include IV bisphosphonates, teriparatide, denosumab, or raloxifene (postmenopausal women only) if oral bisphosphonates are not appropriate. 4

Indications for Surgical Intervention

Surgery should be considered only after failure of at least 6 weeks of optimal conservative management and when specific criteria are met. 2, 1

Absolute Indications for Surgery

  • Severe or progressive neurologic deficits warrant prompt surgical intervention. 2
  • Suspected cauda equina syndrome requires immediate surgical decompression. 2
  • Progressive neurological deficits despite conservative care indicate surgical necessity. 1

Relative Indications for Surgery

  • Persistent severe pain and functional limitations affecting quality of life after 6 weeks of conservative treatment. 2, 1
  • Significant radiculopathy or neurogenic claudication refractory to conservative measures. 2
  • Documented spinal instability on flexion-extension radiographs. 5, 1

Surgical Decision-Making Algorithm

Step 1: Determine if Instability is Present

The presence or absence of instability fundamentally changes the surgical approach. 4, 5

  • If retrolisthesis is associated with spondylolisthesis of any grade, fusion is indicated in addition to decompression. 5, 1
  • If flexion-extension radiographs demonstrate dynamic instability, fusion is recommended. 5
  • If stenosis exists without instability or spondylolisthesis, decompression alone is the recommended treatment. 5, 2

Step 2: Assess for Stenosis and Neural Compression

  • MRI is the preferred imaging modality to evaluate neural compression, providing superior visualization of soft tissue and the spinal canal. 2
  • Upright radiographs with flexion-extension views are essential to identify segmental motion and instability. 2
  • Imaging findings must correlate with clinical symptoms for surgical intervention to be appropriate. 6

Step 3: Select Surgical Approach

For retrolisthesis with stenosis but WITHOUT instability:

  • Decompression alone is the recommended surgical treatment. 5, 2
  • Adding fusion without documented instability increases operative time, blood loss, and surgical risk without proven benefit. 5
  • Only 9% of patients without preoperative instability develop delayed slippage after decompression alone. 5

For retrolisthesis with stenosis AND instability/spondylolisthesis:

  • Decompression with fusion is strongly recommended, with 96% reporting excellent/good results versus 44% with decompression alone. 6, 5, 2
  • Posterolateral fusion with pedicle screw instrumentation is the standard approach. 6, 2
  • Pedicle screw fixation improves fusion success rates from 45% to 83% (p=0.0015) compared to non-instrumented fusion. 5
  • Transforaminal lumbar interbody fusion (TLIF) or posterior lumbar interbody fusion (PLIF) are appropriate techniques, with fusion rates of 92-95%. 6

Step 4: Consider Risk Factors for Iatrogenic Instability

Fusion should be added when extensive decompression might create instability, even if preoperative instability is not documented. 4, 5

  • Extensive decompression without fusion carries a 37.5% risk of late instability development. 5
  • Bilateral facetectomy or removal of >50% of facet joints warrants prophylactic fusion. 5
  • Multilevel laminectomy significantly increases the risk of postoperative instability, with up to 38% developing iatrogenic destabilization. 5

Special Considerations and Common Pitfalls

Critical Pitfalls to Avoid

  • Do not perform fusion for isolated stenosis without evidence of instability—this increases surgical risk without improving outcomes. 5
  • Do not skip formal physical therapy—comprehensive conservative management for at least 6 weeks is mandatory before surgical consideration. 6, 2
  • Do not rely on static imaging alone—flexion-extension radiographs are essential to identify dynamic instability. 2
  • Do not perform multilevel fusion without documenting instability at each level—each level must independently meet fusion criteria. 6

Patient-Specific Factors

  • Retrolisthesis is more common in patients with lower pelvic incidence, smaller lumbar lordosis, and increased thoracolumbar kyphosis. 7
  • The presence of retrolisthesis alone does not predict worse preoperative pain or function compared to patients without retrolisthesis. 8
  • Retrolisthesis appears to serve as a compensatory mechanism for sagittal balance regulation. 7
  • Workers' compensation status is associated with higher prevalence of retrolisthesis. 8

Long-Term Monitoring

  • Regular radiographic assessment is necessary to evaluate fusion status and monitor for adjacent segment disease. 2
  • Monthly maintenance care may be beneficial for patients with relapsing symptoms, with evidence showing gradual reduction in retrolisthesis severity over 13 years. 3
  • Complications to monitor include adjacent segment disease, pseudarthrosis, and need for reoperation. 1

Expected Outcomes

  • Approximately 97% of patients experience some recovery of symptoms after appropriate surgical intervention. 2
  • Decompression with fusion demonstrates superior outcomes in all clinical measures for at least 4 years compared to non-operative management in patients with spondylolisthesis and stenosis. 2
  • Patients with stenosis and spondylolisthesis treated with decompression plus fusion report 93-96% excellent/good outcomes versus 44% with decompression alone. 6, 5
  • Statistically significant improvements occur in back pain (p=0.01) and leg pain (p=0.002) with fusion compared to decompression alone in patients with instability. 6

References

Guideline

Treatment Options for Spinal Stenosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lumbar Spine Fusion for Spinal Stenosis with Neurogenic Claudication

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medical Necessity of Lumbar Fusion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Retrolisthesis and lumbar disc herniation: a preoperative assessment of patient function.

The spine journal : official journal of the North American Spine Society, 2007

Related Questions

What is the management for grade one retrolisthesis of L3 on L4?
What is the recommended treatment for a patient with retrolisthesis?
What is the initial treatment for a patient with retrolisthesis?
What causes retrolisthesis?
What is the treatment for mild retrolisthesis (backward displacement of a vertebra) at L2-L3?
Do patients on apixaban (a direct oral anticoagulant) still require aspirin (acetylsalicylic acid, ASA) 81mg for thromboembolic prevention?
Is anticoagulation (use of blood thinners, such as Low Molecular Weight Heparin (LMWH) or aspirin) necessary during pregnancy in a patient with a history of surgically corrected transposition of the great vessels?
What is the recommended initial dosing for erectile dysfunction (ED) medication, specifically phosphodiesterase type 5 (PDE5) inhibitors such as sildenafil (Viagra) or tadalafil (Cialis), in a patient starting treatment, considering potential interactions with other medications and underlying medical conditions like diabetes, hypertension, and cardiovascular disease?
What is the starting dose of Abilify (aripiprazole) effective for a patient with bipolar disorder and irritability, who is also taking Adderall (amphetamine and dextroamphetamine) for Attention Deficit Hyperactivity Disorder (ADHD)?
What is the injectable treatment for fibrosing alopecia?
Can a patient with Attention Deficit Hyperactivity Disorder (ADHD), depression, and Obsessive-Compulsive Disorder (OCD), currently on Focalin (dexmethylphenidate) and duloxetine, be placed on fluvoxamine for OCD management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.